Abiraterone is an anticancer chemotherapeutic compound that is used to treat castration-resistant prostate cancer. Abiratone inhibits the enzyme Cytochrome p450 17?-hydroxylase (Cyp17), reducing androgen production. This compound may also directly decrease levels of androgen receptor protein expression and inhibit eIF4F signaling.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































